After allegations of data manipulation and substandard generics on Ranbaxy, other generic players like Teva, Par and Sandoz are also facing similar charges either from regulatory agencies or from patients.
Teva Pharma and Par Pharma are facing a lawsuit in which a patient alleged that companies’ generic Pergolide, a treatment for Parkinson’s disease and restless leg syndrome (RLS), caused the valvular heart disease.
Teva Pharma and Par Pharma are facing a lawsuit in which a patient alleged that companies’ generic Pergolide, a treatment for Parkinson’s disease and restless leg syndrome (RLS), caused the valvular heart disease.
Also, Health Canada is warning consumers not to use Sandoz Canada’s Timolol Ophthalmic solution in 0.25% and 0.5%s strengths because solution may contain more of the active ingredient than indicated on the label. The Health Canada announced that it will monitor the effectiveness of Sandoz’s recall, and the company will send a separate communication to doctors and pharmacists. The eyedrops are the generic equivalent of Merck’s Timoptic (Timolol Maleate) and are used to treat increased intraocular pressure and glaucoma.
No comments:
Post a Comment